Search - tctmd.com

Displaying 861 - 880 of 1063

Sort: Relevancy | Date

News Features

Increased Early Risk of Stent Thrombosis With the Absorb Bioresorbable Scaffold

Michael O'Riordan

January 06, 2016

News Daily News

Sweet Surrender? Trimming Sweetness from Sugary Drinks May Cut Obesity-Related Diseases

Todd Neale

January 06, 2016

News Industry News

Renova Therapeutics expands robust gene therapy intellectual property portfolio for cardiovascular and metabolic disease treatments

January 03, 2016

News Daily News

BP Lowering Reduces Vascular Risk Regardless of Baseline BP and Disease History

Michael O'Riordan

December 27, 2015

News Daily News

Bajar la Presión Arterial Reduce el Riesgo Vascular con Independencia de la Presión Arterial Basal y los Antecedentes Patológicos

Michael O'Riordan

December 27, 2015

News Industry News

Cardiome Files New Drug Submission Seeking Canadian Approval of intravenous vernakalant

December 22, 2015

News Daily News

早期数据显示抗血小板药物 PZ-128 效果可逆、起效快速，颇具前景

Caitlin E. Cox

December 20, 2015

News Daily News

Prometedores Primeros Datos para el Fármaco Antiplaquetario Reversible de Acción Rápida PZ-128

Caitlin E. Cox

December 20, 2015

News Daily News

Early Data Show Promise for Reversible, Fast-Acting, Antiplatelet Drug PZ-128

Caitlin E. Cox

December 20, 2015

Presentation

Cell-Penetrating Pepducin Therapy Targeting PAR-1 in Subjects With CAD

Presenter: PA. Gurbel

December 16, 2015

News Daily News

Experts Debate Merits of Guideline-Directed Care for Patients With Multivessel Disease

L.A. McKeown

November 17, 2015

News Industry News

Leviticus Cardio Achieves Successful Transcutaneous Coplanar Energy Transfer in Chronic Animal Model

November 15, 2015

News Conference News AHA 2015

IVUS Tops Angiography for Guiding DES Implantation in Long Lesions

Todd Neale

November 09, 2015

News Conference News AHA 2015

SPRINT Makes Case for Even Lower BP Target in Many Hypertensive Patients

Todd Neale

November 08, 2015

News Conference News AHA 2015

AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More

Shelley Wood

November 05, 2015

News Industry News

Medeon Biodesign Announces Successful First-in-man Studies for Large Bore Vascular Closure Device

November 02, 2015

News Industry News

Tryton Medical Files Pre-Market Approval Application with US FDA for Tryton Side Branch Stent

November 01, 2015

News Daily News

No Money, No Drugs: Global Barriers to Secondary CVD Prevention

Caitlin E. Cox

October 27, 2015

News Industry News

One-Year Outcomes From the COMBO REMEDEE All-Comers Registry Presented at TCT 2015

October 20, 2015

News Conference News TCT 2015

Nordic-Baltic Bifurcation III: Kissing Balloon Dilatation Does Not Reduce MACE at 5 Years

October 16, 2015

Advertisement

Increased Early Risk of Stent Thrombosis With the Absorb Bioresorbable Scaffold

Sweet Surrender? Trimming Sweetness from Sugary Drinks May Cut Obesity-Related Diseases

Renova Therapeutics expands robust gene therapy intellectual property portfolio for cardiovascular and metabolic disease treatments

BP Lowering Reduces Vascular Risk Regardless of Baseline BP and Disease History

Bajar la Presión Arterial Reduce el Riesgo Vascular con Independencia de la Presión Arterial Basal y los Antecedentes Patológicos

Cardiome Files New Drug Submission Seeking Canadian Approval of intravenous vernakalant

早期数据显示抗血小板药物 PZ-128 效果可逆、起效快速，颇具前景

Prometedores Primeros Datos para el Fármaco Antiplaquetario Reversible de Acción Rápida PZ-128

Early Data Show Promise for Reversible, Fast-Acting, Antiplatelet Drug PZ-128

Cell-Penetrating Pepducin Therapy Targeting PAR-1 in Subjects With CAD

Experts Debate Merits of Guideline-Directed Care for Patients With Multivessel Disease

Leviticus Cardio Achieves Successful Transcutaneous Coplanar Energy Transfer in Chronic Animal Model

IVUS Tops Angiography for Guiding DES Implantation in Long Lesions

SPRINT Makes Case for Even Lower BP Target in Many Hypertensive Patients

AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More

Medeon Biodesign Announces Successful First-in-man Studies for Large Bore Vascular Closure Device

Tryton Medical Files Pre-Market Approval Application with US FDA for Tryton Side Branch Stent

No Money, No Drugs: Global Barriers to Secondary CVD Prevention

One-Year Outcomes From the COMBO REMEDEE All-Comers Registry Presented at TCT 2015

Nordic-Baltic Bifurcation III: Kissing Balloon Dilatation Does Not Reduce MACE at 5 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content